Sipuleucel-T drug interactions | Litt's Drug Eruption and Reaction Database

Sipuleucel-T comment watch save

TRADE NAME: Provenge (Dendreon)
INDICATIONS: Treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer
CLASS: Vaccine
HALF-LIFE: N/A

CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Abatacept, Alefacept, Azacitidine, Betamethasone, Cabazitaxel, Denileukin, Docetaxel, Fingolimod, Gefitinib, Lenalidomide, Oxaliplatin, Pazopanib, Pemetrexed, Pralatrexate, Triamcinolone

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Search drug eruptions and reactions data anytime, anywhere

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Hospitalization possible
Life threatening
Fatal

Breast feeding

Geriatric

Pediatric